HMGCR and diabetes mellitus: Although our study demonstrated no direct effects of simvastatin and its active metabolite on adipose tissue metabolism, genetic or pharmacological inhibition of HMG-CoA reductase has been associated with weight gain, which itself is a risk factor for the development of diabetes [15,40] therefore, increased adiposity could be one of the contributors to diabetogenic effects of statins.